Zuckerberg and Sharapova Back Neko Health's $700M AI Body Scan Launch

Neko Health, the AI-powered body scan startup co-founded by Spotify's Daniel Ek and Hjalmar Nilsonne, has closed a $700 million Series C round as it prepares to bring its preventive health clinics to the United States for the first time. The company plans to open new facilities, including one in New York later this year.

A Star-Studded Investor List

The round was led by Lightspeed Venture Partners, with Billionaire Eyal Ofer's fund OG Venture Partners co-leading the investment. The celebrity backer list is notable. Participants include Mark Zuckerberg and Priscilla Chan, Maria Sharapova, Jimmy Iovine, Thierry Henry, Tim Ferriss, will.i.am, Ari Emanuel, Claudia Schiffer, and Danny Meyer, alongside a broad group of existing investors.

The round values the Swedish-born company at nearly $7 billion, marking a roughly fourfold valuation leap from its $1.7 billion Series B milestone in January 2025. That Series B raised $260 million. With this latest close, Neko has now raised over $1 billion in total since launching in 2023.

What the Scan Actually Does

Neko sells a 60-minute, non-invasive, radiation-free body scan that checks skin health, blood sugar levels, blood abnormalities, and risks tied to metabolic syndrome, stroke, and heart attack. Results are read on-site within minutes, and a physician consultation is offered immediately following the scan to review them and recommend next steps. Unlike competitors Prenuvo and Ezra, Neko does not use large medical imaging machines like MRIs for its scans.

The company says more than 100,000 people have already had scans, and more than 350,000 people have either registered for the waitlist or set an appointment. The company also delivered six times more scans in 2025 than in 2024. However, Neko Health has not yet published a full peer-reviewed study demonstrating that its scans improve long-term health outcomes, a point worth noting as the company enters one of the world's most regulated healthcare markets.

Last month, Neko opened its latest clinic in Stockholm, built around the next generation of Neko-engineered medical devices, Derma-2, Echo-2, and Spectrum-2, each upgraded to capture a greater volume and higher fidelity of health signals across skin, heart, and circulation. Its New York clinic will be its largest to date, with more US city announcements expected to follow.

Sources:
Neko Health official press release: $700M Series C
TechCrunch: Daniel Ek's Neko Health raises another $700M
Fierce Healthcare: Neko Health scores $700M to break into the US market